Once-daily dosing of this compound for 7 days in in vivo experiments, not only increased the activation of TrkB in the hippocampus and striatum, but also significantly improved the impairment in motor learning, following traumatic brain injury
[PMC free article] [PubMed] [Google Scholar] [59].DeJong JL, Mohandas T, Tu CP
For weight management, semaglutide affects brain receptors that control appetite, leading to reduced calorie intake and, consequently, weight loss
Curious how they're performing lately
Nanotechnology is being explored to address this issue by creating TQ nanoparticles with higher bioavailability than free TQ
7.2 Comparing with the novel metabolic target drugs As the FXR-activating function of GLP-1RAs, FXR agonists may have the same effect as GLP-1RAs ( In reducing the risk of major adverse liver outcomes and HCC, large-scale observational studies and meta-analyses have demonstrated that GLP-1RA and SGLT2i exhibit comparable protective effects, with both showing significant superiority over traditional hypoglycemic agents such as DPP-4i and sulfonylureas
